Topical wound oxygen therapy in the treatment of severe diabetic foot ulcers: A prospective controlled study

Ostomy Wound Management

Volumn 56, Issue 6, 2010, Pages 24-31

  Blackman, Eric ^a   Moore, Candice ^a   Hyatt, John ^a   Railton, Richard ^a   Frye, Christian ^b  

^a St Catharines Wound Clinic   (Canada)

^b AOTI Ltd   (Ireland)

Author keywords

controlled prospective study; diabetic foot ulcer; outpatients; silver dressing; topical oxygen therapy

Indexed keywords

OXYGEN; SILVER DERIVATIVE;

AGED; ARTICLE; BANDAGE; CANADA; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DRUG EFFECT; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RECURRENT DISEASE; SKIN CARE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; WOUND HEALING; DRUG EFFECTS; PROCEDURES;

ADMINISTRATION, TOPICAL; AGED; BANDAGES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DIABETIC FOOT; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; ONTARIO; OXYGEN; PROSPECTIVE STUDIES; RECURRENCE; SILVER COMPOUNDS; SKIN CARE; TREATMENT OUTCOME; WOUND HEALING; KAPLAN-MEIER ESTIMATE;

EID: 77954074543     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Frykberg R. Diabetic foot ulcers: pathogenesis and management. Am Fam Physicians. 2002;66:1655-1562. (Pubitemid 36068123)
2. Frykberg RG, Zgonis T, Armstrong D, et al. Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45:1-66. (Pubitemid 46187108)
3. Younes NA, Albsoul AM, Awad H. Diabetic heel ulcers: a major risk factor for lower extremity amputation. Ostomy Wound Manage. 2004;50(6):50-60.
4. Driver VA, de Leon JD. Health economic implications for wound care and limb preservation. J Managed Care Med. 2008;11:13-19.
5. Ulbrecht JS, Cavanagh PR, Caputo GM. Foot problems in diabetes: an overview. Clin Infect Dis. 2004;39(suppl 2):73-82.
6. Gordillo GM, Sen CK. Revisiting the essential role of oxygen in wound healing. Am J Surg. 2003;186(3):259-263. (Pubitemid 38368626)
7. Khanna S, Wallace WA. Wound healing: oxygen and emerging therapeutics. Antioxid Redox Signal. 2002;4:961-963.
8. Prockop DJ, Kivirikko KI, Guzman NA. The biosynthesis of collagen and its disorders (part 1). N Engl J Med. 1979;301:13-23.
9. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders (part 2). N Engl J Med. 1979;301:77-85. (Pubitemid 9226521)
10. Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch J Surg. 1997;132:997-1004.
11. Patel V, Chivukula I V, Roy S, et al. Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. Antioxid Redox Signal. 2005;7:1377-1387. (Pubitemid 41232535)
12. Kairuz E, Upton Z, Dawson RA, Malda J. Hyperbaric oxygen stimulates epidermal reconstruction in human skin equivalents. Wound Repair Regen. 2007;15(2):266-274. (Pubitemid 46376389)
13. Hunt TK, Ellison EC, Sen CK. Oxygen: at the foundation of wound healing - introduction. World J Surg. 2004;28:291-293. (Pubitemid 38375531)
14. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database of Systematic Reviews. 2004;2:CD004123.
15. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;7(2):119-124. (Pubitemid 30070823)
16. Fisher BH. Topical hyperbaric oxygen treatment of pressure sores and skin ulcers. Lancet. 1969;2(7617):405-409.
17. Davis SC, Cazzaniga AL, Ricotti C. Topical oxygen emulsion: a novel wound therapy. Arch Dermatol. 2007;143:1252-1256. (Pubitemid 47607675)
18. Fries RB, Wallace WA, Roy S. Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res. 2005;579:172-181. (Pubitemid 41540141)
19. Kalliainen LK, Gordillo GM, Schlanger R, Sen CK. Topical oxygen as an adjunct to wound healing: a clinical case series. Pathophysiology. 2003;9:81-87. (Pubitemid 37297329)
20. Heng MC, Harker J, Csathy G, et al. Angiogenesis in necrotic ulcers treated with hyperbaric oxygen. Ostomy Wound Manage. 2000;46(3):18-32.
21. Heng MCY. Enhanced healing and cost-effectiveness of low pressure oxygen therapy in healing necrotic wounds: a feasibility study of technology transfer. Ostomy Wound Manage. 2000;46(3):52-62.
22. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic wounds. J Foot Ankle Surg. 1996;35(6):528-531.
23. Edmonds, M, European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds. 2009;8(1):11-18.
24. Armstrong D, Lavery L, Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005; 336:1704-1710. (Pubitemid 41587449)
25. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008;31(4):631-636.
26. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002;137(7):822-827. (Pubitemid 34743174)
27. Reyzelman A, Crews RT, Moore JC, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot. Int Wound J. 2009;6(3):196-208.
28. Sibbald RG, Woo KY. Wound bed preparation and oxygen balance - a new component? Int Wound J. 2007;4(suppl):9-17.
29. Sen CK. Wound healing essentials: let there be oxygen. Wound Rep Reg. 2009;17:1-18.
30. Jonsson K, Jensen JA, Goodson WH III, et al. Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surgery. 1991;214:605-613.
31. Allen DB, Maguire JJ, Mahdavian M, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg. 1997;132:991-996. (Pubitemid 27386358)
32. Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S. Oxygen, oxidants, and antioxidant in wound healing: an emerging paradigm. Ann NY Acad Sci. 2002;957:239-249.
33. Scott G, Reeves R. Topical Oxygen Alters Angiogenesis Related Growth Factor Expression in Chronic Diabetic Foot Ulcers. Poster presented at the Symposium on Advanced Wound Care. San Diego, CA. April 21-24, 2005.
34. Gordillo GM, Roy S, Khanna S, et al. Topical oxygen therapy induces vascular endothelial growth factor expression and improves closure of clinically presented chronic wounds. Clin Exp Pharmacol Physiol. 2008;35:957-964. (Pubitemid 351951942)
35. Landau Z. Topical hyperbaric oxygen and low energy laser for the treatment of diabetic foot ulcers. Arch Orthop Trauma Surg. 1997;117:156-158. (Pubitemid 28072541)
36. 2) offer an improved outcome over conventional compression dressings (CCD) in the management of refractory venous ulcers (RVU)? A parallel observational comparative study. Eur J Vasc Endovasc Surg. 2009;38(1):125-132.
37. World Health Organisation. Available at: https://apps.who.int/infobase/ reportviewer.aspx?uncode=682&rptcode=BCP&dm=2#pgstring2. Accessed May 30, 2010.
38. Aulivola B, Hile CN, Hamdan AD. Major lower extremity amputation: outcome of a modern series. Arch Surg. 2004;139:395-399. (Pubitemid 38451582)
39. Sedory Holzer SE, Camerota A, Martens L. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20:169-181. (Pubitemid 28126290)
40. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: National Diabetes Data Group. Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health, NIDDK, NIH:1995.